The prognostic value of systemic clearance of methotrexate (MTX) has been evaluated in 58 children with acute lymphoblastic leukemia, receiving altogether 380 MTX infusions in a dose range of 0.5 to 33.6 g/mZ. The linear regression analysis of dose-steady state concentration relationship revealed th
Prognostic importance of systemic clearance of methotrexate in childhood acute lymphoblastic leukemia
โ Scribed by Joseph D. Borsi; Thomas Revesz; Dezso Schuler
- Book ID
- 104683642
- Publisher
- Springer
- Year
- 1987
- Tongue
- English
- Weight
- 341 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Background Tromboembolic and hemorrhagic complications are significant causes of death in patients with malignancy. These are wellโknown with the use of certain drugs. This study was planned to investigate whether there was any effect of highโdose methotrexate on the hemostatic syst
Two groups of children with refractory acute lymphoblastic leukemia were treated with a regimen of methotrexate (MTX) and asparaginase (Asn'ase) based on studies of the effect of MTX in vitro on human lymphoblasts exposed to Asn'ase. Induction therapy in 12 children produced 4 complete remissions, 3
Children with ALL who have a high probability of excellent response, long-term survival, and cure when treated with widely available standard therapy can be identified at the time of diagnosis. Others can be identified who are at high risk of failure to respond, early relapse, and death. The importa
## BACKGROUND. Although it is widely accepted that failure to achieve complete remission (CR) portends a poor prognosis in childhood acute lymphoblastic leukemia (ALL), there is variability in the precise definition of induction failure and, to the authors' knowledge, few published data exist regar